GlassScriptPhysician profile
Michael Gerard Dulske
NPI 1972691020
$10,187.03
in general payments reported to CMS, 2019-2025
29 companies · $2,483 in 2025
The $2,483 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $1,591 · 2021: $200 · 2022: $3,947 · 2023: $1,148 · 2024: $142 · 2025: $2,483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,072 · Food and Beverage: $1,702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,071.56 |
| Food and Beverage | $1,701.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $3,335.16 | 2020-2025 | |
| Smith+Nephew, INC. | $2,776.85 | 2019-2023 | N/A, Lens, Real Intelligence |
| Arthrex, INC. | $1,727.02 | 2022-2025 | |
| Catalyst Orthoscience | $665.64 | 2023 | R1 Reverse Total Shoulder, Csr & R1 Reverse Total Shoulder Systems, Archer 3d Software |
| Pacira Therapeutics, INC. | $380.83 | 2019-2021 | |
| Depuy Synthes Sales INC. | $226.68 | 2019 | |
| Abbott Laboratories | $154.41 | 2022 | |
| Stryker Corporation | $135.04 | 2021-2023 | Inspace |
| Vertex Pharmaceuticals Incorporated | $79.80 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $78.84 | 2022-2023 | Seglentis |
| Pacira Pharmaceuticals Incorporated | $68.17 | 2022-2025 | Iovera, Zilretta, Exparel |
| Amgen INC. | $67.15 | 2019-2023 | Evenity, Prolia |
| Kerecis Limited | $66.35 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Horizon Therapeutics Plc | $55.98 | 2019-2022 | |
| Ethicon US, LLC | $54.21 | 2022-2024 | Ethicon |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $40.50 | 2023 | Magnetom Altea, Magnetom Free.Max, Magnetom Lumina |
| Ferring Pharmaceuticals INC. | $40.19 | 2025 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $40.16 | 2020-2021 | |
| Pfizer INC. | $28.10 | 2020 | |
| Vericel Corporation | $21.25 | 2022 | |
| Philips North America LLC | $21.07 | 2023 | |
| Total Joint Orthopedics, INC. | $21.04 | 2024 | |
| Trevena, INC. | $18.78 | 2021 | |
| Bioventus LLC | $17.38 | 2021 | |
| Davol INC. | $16.42 | 2024 | Arista Ah Flexitip |
| Zyla Life Sciences, INC. | $13.52 | 2020 | |
| Heron Therapeutics, INC. | $12.57 | 2021 | |
| Molnlycke Health Care US, LLC | $12.06 | 2024 | Mepilex Border Post-Op Ag |
| Arthrosurface Incorporated | $11.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dulske listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.